Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.33 |
| ▸ | BAD | Q92934 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL31607698 | 0.98 | TSHR (0.48) | TSHRHPGDL3MBTL1BCL2L1BAD | |
| SCHEMBL16684913 | 0.98 | TSHR (0.48) | TSHRHPGDL3MBTL1BCL2L1BAD | |
| SCHEMBL20477815 | 0.84 | TSHR (0.38) | TSHRCYP2A6MAOBHTR2C | |
| SCHEMBL8661929 | 0.81 | TSHR (0.30) | TSHR | |
| SCHEMBL62945 | 0.80 | TSHR (0.52) | TSHRHPGDL3MBTL1BCL2L1BAD | |
| SCHEMBL9421049 | 0.80 | TSHR (0.52) | TSHRHPGDL3MBTL1BCL2L1BAD | |
| SCHEMBL177122 | 0.78 | TSHR (0.50) | TSHRHPGDL3MBTL1BCL2L1BAD | |
| SCHEMBL327799 | 0.76 | TSHR (0.43) | TSHRCYP2A6MAOAMAOBHTR2C | |
| SCHEMBL31251596 | 0.76 | TSHR (0.43) | TSHRCYP2A6MAOAMAOBHTR2C | |
| SCHEMBL3884 | 0.73 | TSHR (0.48) | TSHRHPGDL3MBTL1BCL2L1BAD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119331240-A | Benzocyclooctyne-polyethylene glycol modified halofuginone and preparation method and application thereof | 南京大学 | 2025-01-21 | — | — | CN | claimed |
| CN-118409092-B | Aptamer functionalized magnetic bead for interferon gamma detection, preparation method thereof and kit | 上海市肺科医院（上海市职业病防治院） | 2024-10-18 | — | — | CN | claimed |
| CN-118409092-A | Aptamer functionalized magnetic bead for interferon gamma detection, preparation method thereof and kit | 上海市肺科医院（上海市职业病防治院） | 2024-07-30 | — | — | CN | claimed |
| WO-2023175063-A1 | METHOD FOR SEPARATING HIGH-METHYLATED DNA AND LOW-METHYLATED DNA | UNIVERSITEIT TWENTE (NL) | 2023-09-21 | — | — | WO | claimed |
| WO-2023128875-A2 | METHOD OF BACTERIAL IDENTIFICATION AND TESTING OF BACTERIUM RESISTANT TO ONE OR MORE ANTIBIOTICS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2023-07-06 | — | — | WO | claimed |
| US-20230044430-A1 | COMPOSITION AND METHOD FOR MODIFYING POLYPEPTIDES | KRANTZ ALEXANDER (US) | 2023-02-09 | — | — | US | claimed |
| WO-2017196544-A1 | NOVEL COMPOSITIONS FOR LABELING BIOMOLECULES AND METHODS USING SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-11-16 | — | — | WO | claimed |
| WO-2013013820-A1 | FUNCTIONALIZATION OF RNA OLIGONUCLEOTIDES | Universität Heidelberg (DE) | 2013-01-31 | — | — | WO | claimed |
| EP-2551354-A1 | Functionalization of RNA oligonucleotides | Universität Heidelberg (DE) | 2013-01-30 | — | — | EP | claimed |
| CN-119331240-B | Benzocyclooctyne-polyethylene glycol modified halofuginone and preparation method and application thereof | 南京大学 | 2026-01-02 | — | — | CN | disclosed |
| WO-2025087235-A1 | NUCLEIC ACID APTAMER-DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION, AND USE THEREOF | 北京华睿鼎信科技有限公司 | 2025-05-01 | — | — | WO | disclosed |
| CN-116693590-B | Fusidic acid derivative and preparation method and application thereof | 南京工业大学 | 2025-03-18 | — | — | CN | disclosed |
| CN-119331240-A | Benzocyclooctyne-polyethylene glycol modified halofuginone and preparation method and application thereof | 南京大学 | 2025-01-21 | — | — | CN | disclosed |
| CN-119331240-A | Benzocyclooctyne-polyethylene glycol modified halofuginone and preparation method and application thereof | 南京大学 | 2025-01-21 | — | — | CN | disclosed |
| WO-2013013820-A1 | FUNCTIONALIZATION OF RNA OLIGONUCLEOTIDES | Universität Heidelberg (DE) | 2013-01-31 | — | — | WO | disclosed |
| EP-2551354-A1 | Functionalization of RNA oligonucleotides | Universität Heidelberg (DE) | 2013-01-30 | — | — | EP | disclosed |
| US-20120190098-A1 | FLUOROGENIC COMPOUNDS CONVERTED TO FLUOROPHORES BY PHOTOCHEMICAL OR CHEMICAL MEANS AND THEIR USE IN BIOLOGICAL SYSTEMS | LELAND STANFORD JUNIOR UNIVERSITY (US) | 2012-07-26 | — | — | US | disclosed |
| WO-2012047663-A2 | METHODS INCLUDING LATENT 1,3-DIPOLE-FUNCTIONAL COMPOUNDS AND MATERIALS PREPARED THEREBY | UNIVERSITY OF GEORGIA REASERCH FOUNDATION, INC. (US) | 2012-04-12 | — | — | WO | disclosed |
| US-8153446-B2 | Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems | KENT STATE UNIVERSITY (US) | 2012-04-10 | — | — | US | disclosed |
| US-20100029952-A1 | Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems | KENT STATE UNIVERSITY (US) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230044430-A1 | COMPOSITION AND METHOD FOR MODIFYING POLYPEPTIDES | PTMS, SRMS, ACP1 | TSHR 1068/4885HPGD 4632/4885L3MBTL1 910/4885 |
| US-20120190098-A1 | FLUOROGENIC COMPOUNDS CONVERTED TO FLUOROPHORES BY PHOTOCHEMICAL OR CHEMICAL MEANS AND THEIR USE IN BIOLOGICAL SYSTEMS | MPI, ACR, PFAS | TSHR 2426/4885HPGD 1767/4885L3MBTL1 1877/4885 |
| US-20100029952-A1 | Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems | MPI, ACR, PFAS | TSHR 2426/4885HPGD 1767/4885L3MBTL1 1877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.